Published in Clinical Oncology Week, March 23rd, 2009
The MastaScope™ has been developed and designed to assist in detection of breast cancer. The Company will now evaluate the competition and market for this product, as well as its potential of being a complementary product to Lifeline’s First Warning early...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.